Biomatter Raises $18M Series A Led by Agrifood Investor Astanor to Scale AI Enzyme Design
Save
Investments & Finance

Biomatter Raises $18M Series A Led by Agrifood Investor Astanor to Scale AI Enzyme Design

Vegconomist • Nov 20, 2026
Biomatter, a Vilnius-based enzyme design company, has successfully raised $18 million in an oversubscribed Series A funding round led by agrifood investor Astanor. The investment will be utilized to establish a 2,000 m² enzyme design and testing facility in Vilnius, set to open in 2027, along with enhancing the company’s commercial presence in the US. Founded in 2018, Biomatter focuses on leveraging AI and physics-based models to create custom enzymes tailored to specific chemical reactions for various clients, including Tereos and Sanofi.

The company has provided over 50 custom enzymes to more than 25 enterprise customers, aiming to streamline production processes. The new facility is expected to significantly reduce the time for enzyme delivery from weeks to days. As the global demand for enzymes in food and biomanufacturing continues to rise, Biomatter joins a growing trend of companies utilizing AI in enzyme and protein engineering, highlighting its potential in advancing fermentation and food safety solutions.
*This summary was generated using AI.
Read Full Article